Operable gastro-oesophageal junctional adenocarcinoma: Where to next?
Explore this paper's citation graph
Summary
The benefits of neoadjuvant, peri-operative, and post-operative chemotherapy and chemoradiotherapy in this setting are examined in an attempt to reach an evidence based conclusion.
- Type
- article
- Published
- 2014-06-15
- Cited by
- 2
- References
- 83
- OpenAlex
- https://openalex.org/W24936225
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:36149573
Keywords
Training (meteorology), Computer science, Geography
References
- A randomized, prospective cross-over trial comparing methylene blue-directed biopsy and conventional random biopsy for detecting intestinal metaplasia and dysplasia in Barrett's esophagus.
- REVIEW: Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
- Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up.
- Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
- Meta‐analysis: the association of oesophageal adenocarcinoma with symptoms of gastro‐oesophageal reflux
- Review of salt consumption and stomach cancer risk: epidemiological and biological evidence.
- Dihydropyrimidine dehydrogenases and cytidine‐deaminase gene polymorphisms as outcome predictors in resected gastric cancer patients treated with fluoropyrimidine adjuvant chemotherapy
- Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease.
- Familial aggregation of Barrett’s oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults
- Aspirin Protects Against Barrett’s Esophagus in a Multivariate Logistic Regression Analysis
- The genomic landscape of oesophagogastric junctional adenocarcinoma
- Treatment modality and risk of development of dysplasia and adenocarcinoma in columnar-lined esophagus.
- Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus
- Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes
- Intrinsic Subtypes of Gastric Cancer, Based on Gene Expression Pattern, Predict Survival and Respond Differently to Chemotherapy
- Prevalence of Barrett's Esophagus in first degree relatives of patients with esophageal adenocarcinoma
- Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer).
- Helicobacter pylori: gastric cancer and beyond
- Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.
- PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.